Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rimage Corp Announces Adoption Of 10b5-1 Plan For Its Stock Repurchase Program


Monday, 5 Nov 2012 04:05pm EST 

Rimage Corp announced that its Board of Directors has approved a Rule 10b5-1 plan in connection with its previously announced expanded stock repurchase program. The Rule 10b5-1 plan will give the Company the ability to repurchase its shares under the expanded stock repurchase program at times when it otherwise might be prevented from doing so under insider trading laws or because of self-imposed blackout periods. As previously disclosed, on October 26, 2012, the Rimage Board of Directors approved the repurchase of an additional 2,000,000 shares of the Company’s stock under the Company’s stock repurchase program. With the approximately 182,000 shares remaining under the previous authorization, there were a total of approximately 2,182,000 shares authorized for repurchase at October 26, 2012. 

Company Quote

8.09
0.08 +1.00%
23 May 2013